Bank of New York Mellon
ONCR

Bank of New York Mellon’s Oncorus, Inc. ONCR Stock Holding History

Bank of New York Mellon’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-66,498
Closed -$22.9K – 4500
2023
Q1 		$22.9K Hold
66,498
– – ﹤0.01% 4294
2022
Q4 		$16.8K Sell
66,498
-497
-0.7% -$283 ﹤0.01% 4373
2022
Q3 		$57K Sell
66,995
-30
-0% -$38 ﹤0.01% 4301
2022
Q2 		$84K Sell
67,025
-55,022
-45% -$74.7K ﹤0.01% 4265
2022
Q1 		$218K Buy
122,047
+62,985
+107% +$176K ﹤0.01% 4193
2021
Q4 		$312K Buy
59,062
+1,066
+2% +$8.25K ﹤0.01% 4077
2021
Q3 		$542K Buy
57,996
+8,059
+16% +$92K ﹤0.01% 3767
2021
Q2 		$690K Buy
49,937
+32,192
+181% +$497K ﹤0.01% 3621
2021
Q1 		$247K Buy
17,745
+277
+2% +$5.74K ﹤0.01% 3985
2020
Q4 		$565K Buy
+17,468
New +$404K ﹤0.01% 3561

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Bank of New York Mellon's ONCR Position: Q2 2023 in Review

Bank of New York Mellon sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 66,498 shares — an estimated $22.9K sold.

Bank of New York Mellon first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $690K in Q2 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Bank of New York Mellon reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 66,498 Oncorus, Inc. shares in Q2 2023, an estimated $22.9K.
  • Bank of New York Mellon first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • Bank of New York Mellon's Oncorus, Inc. position peaked at $690K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.